Your only mesothelioma treatment news source!
Click on each item to read full story.
|
LegalView Updates Mesothelioma Victims on a Push to Increase Federal Funding for Asbestos-Related Illnesses and Deaths (PRWeb)
read story
LegalView reported to mesothelioma blog readers that several U.S. senators and lobbyists are supporting a push to increase federal funding for researching asbestos-related illnesses. The 2009 defense appropriations bill is at the epicenter for the cancer research because of the vast array of Navy men who are currently diagnosed with mesothelioma and at risk for the condition. (PRWeb May 20, ...
|
| |
LegalView Updates Mesothelioma Victims on a Push to Increase Federal Funding for Asbestos-Related Illnesses and Deaths (PRWeb via Yahoo! News)
read story
LegalView reported to mesothelioma blog readers that several U.S. senators and lobbyists are supporting a push to increase federal funding for researching asbestos-related illnesses. The 2009 defense appropriations bill is at the epicenter for the cancer research because of the vast array of Navy men who are currently diagnosed with mesothelioma and at risk for the condition. |
| |
Chemotherapy Does Not Improve Treatment For Mesothelioma (Medical News Today)
read story
For mesothelioma patients, the addition of chemotherapy to the usualactive symptom control (ASC) does not appear to improve survival orquality of life, according to an article released on May 16, 2008 in TheLancet. Malignant pleural mesothelioma (MPM) is cancer of the mesothelium, theprotective layer that covers the lungs. |
| |
Chemo for Mesothelioma Offers Limited Survival Benefits (MedicineNet.com)
read story
Title: Chemo for Mesothelioma Offers Limited Survival Benefits Category: Health News Created: 5/16/2008 2:00:00 AM Last Editorial Review: 5/16/2008 |
| |
Chemo for Mesothelioma Offers Limited Survival Benefits (HealthDay via Yahoo! News)
read story
THURSDAY, May 15 (HealthDay News) -- Adding chemotherapy to other treatments being giving to patients with mesothelioma, a lung cancer usually linked to asbestos exposure, does not appear to improve either survival or quality of life. |
| |
Fighting Cancer: Historic Anti-Asbestos Legislation Moving Forward With Support of Meso Foundation (PR Newswire via Yahoo! News)
read story
Six years ago, Senator Patty Murray (D-WA) first introduced her proposed legislation to ban asbestos and invest federal funding in the research critically needed to develop effective treatments for the vicious cancer, mesothelioma, and other asbestos related diseases. Since 2002, the Mesothelioma Applied Research Foundation (Meso Foundation) has worked closely with Senator Murray to stop the ... |
| |
Asbestos-Induced Lung Cancer Patients Do Not Appear To Benefit From Chemotherapy, UK (Medical News Today)
read story
Adding chemotherapy to established methods of symptom management does not appear to enhance the quality of life or survival of patients suffering from an asbestos-induced form of lung cancer called malignant plural mesothelioma (MPM). |
| |
Chemo for Mesothelioma Offers Limited Survival Benefits (HealthCentral.com)
read story
Copyright © 2008 ScoutNews LLC. All rights reserved. THURSDAY, May 15 (HealthDay News) -- Adding chemotherapy to other treatments being giving to patients with mesothelioma, a lung cancer usually linked to asbestos exposure, does not appear to improve either survival or quality of life. |
| |
Chemo for Mesothelioma Offers Limited Survival Benefits (ABC 7 El Paso)
read story
THURSDAY, May 15 (HealthDay News) -- Adding chemotherapy to other treatments being giving to patients with mesothelioma, a lung cancer usually linked to asbestos exposure, does not... |
| |
Asbestos-induced lung cancer patients do not appear to benefit from chemotherapy (News-Medical-Net)
read story
Adding chemotherapy to established methods of symptom management does not appear to enhance the quality of life or survival of patients suffering from an asbestos-induced form of lung cancer called malignant plural mesothelioma (MPM). These are the results of MS01, a large UK and Australian study published in the Lancet, which set out to assess the potential benefits of combining active symptom ... |
| |